Issuers of listed transferable securities are required to provide Oslo Stock Exchange with an annual summary of information made available to the public, cf the Stock Exchange Regulations, section 5-2, §5.

Please find the annual overview for Pronova BioPharma ASA (OSE: PRON.OL) attached. The overview includes all announcements made available in 2011.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
Annual overview 2011:
http://hugin.info/137506/R/1575889/490944.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Pronova BioPharma ASA via Thomson Reuters ONE
HUG#1575889